Aspen API. More than just an API.
01 1Aspen Oss B.V.
02 1Bachem Americas, Inc.
03 1Aurobindo Pharma Limited
04 1BCN PEPTIDES SA
05 16Hemmo Pharmaceuticals Pvt. Ltd
06 6Piramal Pharma Limited
07 1PolyPeptide Laboratories (Sweden) AB
08 4Zhejiang Supor Pharmaceuticals Co., Ltd
01 1ARGIPRESSIN
02 1Degarelix Acetate
03 1Plecanatide
04 1Sermorelin Acetate
05 1VASOPRESSIN
06 26Vasopressin
01 4China
02 1India
03 1Netherlands
04 1Spain
05 2Switzerland
06 22U.S.A
Aspen API. More than just an API.
NDC Package Code : 60870-0277
Start Marketing Date : 1980-04-25
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.
NDC Package Code : 52416-127
Start Marketing Date : 2019-05-16
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 35207-0005
Start Marketing Date : 2012-07-25
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 41701-008
Start Marketing Date : 2016-03-28
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (0.3g/.3g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 41701-008
Start Marketing Date : 2016-03-28
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 41701-008
Start Marketing Date : 2016-03-28
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1.5g/1.5g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 14799-3002
Start Marketing Date : 2018-03-06
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 14799-3003
Start Marketing Date : 2022-06-15
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 14799-3001
Start Marketing Date : 2014-04-17
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 14799-3004
Start Marketing Date : 2024-05-17
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
A Argipressin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Argipressin, including repackagers and relabelers. The FDA regulates Argipressin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Argipressin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Argipressin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Argipressin supplier is an individual or a company that provides Argipressin active pharmaceutical ingredient (API) or Argipressin finished formulations upon request. The Argipressin suppliers may include Argipressin API manufacturers, exporters, distributors and traders.
click here to find a list of Argipressin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Argipressin as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Argipressin API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Argipressin as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Argipressin and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Argipressin NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Argipressin suppliers with NDC on PharmaCompass.
We have 7 companies offering Argipressin
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
